Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Elsevier Masson is a leading French publisher and information provider specializing in the fields of medicine, nursing, and health sciences. The company was formed through the merger of the historic Masson publishing house, founded in 1804, and Elsevier's French operations. It provides a comprehensive range of products including over 100 scientific journals, medical textbooks, and digital clinical decision support tools like EM-Consulte and ClinicalKey. Elsevier Masson serves a diverse audience of healthcare professionals, researchers, and students, primarily within the French-speaking market. As a subsidiary of Elsevier, it leverages global scientific networks while maintaining a strong local presence in the French medical community. The company is also well-known for publishing the Encyclopédie Médico-Chirurgicale (EMC), a major reference work in the medical field.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Elsevier Masson.